Latest results FY2026 · Prices updated Oct 30, 2026
HQ: Tokyo, TokyoFounded 1969145 employeesWebsite
A healthcare company operating in diagnostics, life sciences, and diabetes management. It provides medical products and services to customers in Japan and worldwide.
Business segments (share of revenue)
Latest results
FY2026
vs. same period a year earlier
Company forecastFY2027
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Healthcare Solutions and Services | 35% | ¥128.4B | ¥6.2B | 4.9% |
| Diagnostics and Life Sciences | 35% | ¥128.3B | ¥3.9B | 3.0% |
| Diabetes Management Solutions | 28% | ¥101.6B | ¥20.1B | 19.8% |
| Other and Adjustments/Eliminations | 2% | ¥6.1B | ¥-7.5B | -123.2% |
Close (Oct 30, 2026)
¥1,415+37.1% (1Y)
PHC +37.1% over 1Y, 33.2pt above the industry average (9 companies, +3.9%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2026FY | ¥364.4B | ¥22.7B | ¥492M | ¥542.5B | — |
Sources: annual securities reports, earnings releases and other public disclosures (Mar 2026)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
